Fig. 13
From: The use of RNA-based treatments in the field of cancer immunotherapy
Obstacles in delivering and administering lipid nanoparticle-mRNA concoctions. a Natural hurdles faced by lipid nanoparticle-mRNA (LNP-mRNA) mixtures following systemic and localized distribution. b Methods of delivering LNP-mRNA compounds. Reprinted from [551] with permission from Springer Nature